PET放射性追蹤劑的全球市場

到 2030 年，PET 放射性示蹤劑全球市場規模將達到 59 億美元

全球PET放射性示蹤劑市場規模預計在2024年為37億美元，到2030年將達到59億美元，2024年至2030年的複合年成長率為8.4%。 F-18放射性示蹤劑是本報告分析的細分市場之一，預計其複合年成長率為9.6%，到分析期結束時市場規模將達到42億美元。 Ga-68放射性示蹤劑細分市場在分析期間內的複合年成長率預計為5.5%。

美國市場規模估計為 9.992 億美元，中國市場預計複合年成長率為 13.2%

美國PET放射性示蹤劑市場規模預計2024年達到9.992億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到13億美元，在2024-2030年的分析期間內，複合年成長率為13.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.1%和8.0%。在歐洲，預計德國市場的複合年成長率為5.6%。

全球 PET 放射性追蹤劑市場 - 主要趨勢與促進因素摘要

為什麼 PET 放射性追蹤劑在現代診斷影像中處於領先地位？

正子斷層掃描 (PET) 放射性追蹤劑已成為高階診斷影像的基礎工具，尤其是在腫瘤學、神經病學和心臟病學領域。這些放射性藥物是用正電子發射同位素標記的生物活性分子，使臨床醫生能夠在細胞層面上觀察代謝和分子活動。與結構成像不同，PET 研究能夠提供疾病進展、早期檢測和治療反應的功能性洞察，因此對精準醫療至關重要。

由於癌症發生率的上升、臨床應用的不斷拓展以及三級醫療機構中PET-CT和PET-MRI混合系統的整合，全球PET放射性示蹤劑市場正經歷強勁成長。腫瘤學仍然是主要的應用領域，其中18F-FDG（氟脫氧葡萄糖）在臨床應用中佔比最大。然而，新型示蹤劑，例如用於神經內分泌腫瘤的68Ga-DOTATATE和用於復發性前列腺癌的18F-氟環丙沙星，正在迅速豐富診斷領域。

此外，對核醫基礎設施（例如迴旋加速器設施和放射性藥物網路）的持續投資，正在改善區域內PET示蹤劑的可近性。美國、歐洲和亞太地區的監管機構正在簡化臨床實驗放射性藥物的核准流程，加速臨床試驗和商業性部署。在產學合作的支持下，這個不斷發展的生態系統正在推動全球PET放射性追蹤劑市場超越傳統癌症診斷領域。

技術進步如何影響放射性示蹤劑的開發與交付？

PET放射性追蹤劑的技術創新在很大程度上依賴於同位素生產、放射化學自動化以及示蹤劑特異性標靶機制的進步。迴旋加速器的小型化和基於發生器的同位素系統（例如68Ge/68Ga發生器）的引入，促進了放射性示踪劑的現場或近現場生產，從而緩解了傳統集中式供應鏈中與半衰期相關的限制。這有助於擴大放射性示蹤劑的可近性，尤其是在新興市場和偏遠醫療機構。

目前，靶向放射性示蹤劑的設計正在提高受體特異性，使臨床醫生能夠區分腫瘤亞型並在分子層面監測治療效果。例如，18F-FES 針對乳癌中的雌激素受體，而基於 PSMA 配體的示蹤劑正在重塑前列腺癌的診斷和治療診斷。在神經病學領域，18F-florbetapir 和 18F-fortaucipir 正用於對阿茲海默症中的澱粉樣蛋白和Tau病理進行成像，從而支持認知能力下降的早期診斷。

放射性示蹤劑合成自動化平台，例如盒式合成模組和微流體晶片，正在減少人為錯誤、提高純度並加快生產時間。放射性藥物製造商也正在開發冷試劑套件和即用型注射劑，以標準化流程並降低醫護人員的輻射暴露風險。隨著放射性藥物不斷發展以滿足特定疾病的診斷需求，技術是實現擴充性、效率和安全性的關鍵推動因素。

哪些臨床應用和地區將推動市場成長？

雖然腫瘤學仍然是 PET 放射性追蹤劑的核心市場，但神經病學和循環系統的新適應症正在推動其成長。阿茲海默症診斷領域正在開闢新的成長途徑，這得益於澱粉樣蛋白和Tau PET 成像的日益普及以及疾病修正治療的核准。同樣，使用 13N-氨和 82Rb 等灌注示蹤劑的心臟 PET 影像有助於評估複雜冠狀動脈疾病患者的心肌活力和缺血情況。

從地理上看，北美憑藉其強大的放射性藥物生產基礎、高昂的人均醫療保健支出以及先進的影像中心，依然佔據主導地位。美國食品藥物管理局 (FDA) 正在透過「藥物主文件系統」(Drug Master File) 和放射性藥物研究委員會 (RDRC) 框架等舉措，支持放射性示蹤劑的開發，以促進創新。德國、英國和法國憑藉其成熟的核子醫學部門和日益壯大的 PET-MRI 設施，在放射性追蹤劑的應用方面處於領先地位。

亞太地區是成長最快的地區，日本、中國和韓國等國家正在投資國內同位素生產並擴大PET成像基礎設施。印度在PET示蹤劑開發方面，尤其是在三級癌症中心，官民合作關係正在增強。拉丁美洲和中東部分地區已初顯應用徵兆，但受到基礎設施缺口和高昂採購成本的限制。

推動全球 PET 放射性追蹤劑市場成長的因素有哪些？

全球 PET 放射性追蹤劑市場的成長受到癌症和神經退化性疾病盛行率上升、混合成像模式的日益普及、核醫學基礎設施的快速擴張以及針對疾病的示踪劑設計的持續創新的推動。隨著精準診斷成為現代醫療保健的核心，對提供早期、準確和可操作見解的放射性示踪劑的需求激增。

主要成長動力包括政府對放射性藥物研發的支持、法規結構的簡化以及放射化學自動化的進步。臨床轉向價值導向醫療和個人化醫療，正鼓勵醫院採用分子影像工具，以減少診斷不確定性並改善治療效果。私人企業正積極響應這一趨勢，不斷增加放射性示蹤劑的研發管線、建立強大的供應網路，並開發用於標靶治療的伴隨診斷產品。

此外，教育措施和核子醫學培訓計畫正在加強全球放射性藥劑師人才庫，並有助於確保示蹤劑處理安全和合規。隨著臨床專業和地區的需求不斷多樣化，PET 放射性示蹤劑市場已準備好迅速擴張，並確立其作為下一代醫學影像基石的地位。

部分

放射性示蹤劑（F-18放射性追蹤劑、Ga 68放射性追蹤劑、其他放射性追蹤劑類型）；應用（癌症、心臟病學、胃腸道、內分泌、神經系統疾病等）；最終用戶（醫院、診斷中心等）

受訪公司範例

• ABX Advanced Biochemical Compounds GmbH
• Advanced Accelerator Applications
• AstraZeneca PLC
• Avid Radiopharmaceuticals
• Blue Earth Diagnostics
• Cardinal Health Inc.
• Eli Lilly and Company
• GE HealthCare
• IBA Radiopharma Solutions SA
• ImaginAb Inc.
• IXICO PLC
• Jubilant Pharma Limited
• Lantheus Holdings Inc.
• Neusoft Medical Systems Co. Ltd.
• Nordion Inc.
• Positron Corporation
• Radiomedix Inc.
• Siemens Healthineers AG
• SOFIE Biosciences Inc.
• Yantai Dongcheng Pharmaceutical

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有查詢通用的 LLM 或特定產業的SLM，而是建立了一個來自世界各地專家的精選內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global PET Radiotracers Market to Reach US$5.9 Billion by 2030

The global market for PET Radiotracers estimated at US$3.7 Billion in the year 2024, is expected to reach US$5.9 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. F-18 Radiotracer, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$4.2 Billion by the end of the analysis period. Growth in the Ga 68 Radiotracer segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$999.2 Million While China is Forecast to Grow at 13.2% CAGR

The PET Radiotracers market in the U.S. is estimated at US$999.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global PET Radiotracers Market - Key Trends & Drivers Summarized

Why Are PET Radiotracers Gaining Traction in Modern Diagnostic Imaging?

Positron Emission Tomography (PET) radiotracers have become foundational tools in advanced diagnostic imaging, particularly in oncology, neurology, and cardiology. These radiopharmaceuticals, which are biologically active molecules labeled with positron-emitting isotopes, enable clinicians to visualize metabolic and molecular activity at a cellular level. Unlike structural imaging modalities, PET scans offer functional insights into disease progression, early detection, and treatment response, making them indispensable in precision medicine.

The global PET radiotracers market is experiencing robust growth due to increasing cancer prevalence, expanding clinical applications, and the integration of PET-CT and PET-MRI hybrid systems in tertiary healthcare facilities. Oncology remains the dominant application area, with 18F-FDG (fluorodeoxyglucose) accounting for the largest share of clinical usage. However, novel tracers like 68Ga-DOTATATE for neuroendocrine tumors and 18F-fluciclovine for prostate cancer recurrence are rapidly diversifying the diagnostic landscape.

Furthermore, rising investments in nuclear medicine infrastructure-such as cyclotron facilities and radiopharmacy networks-are improving regional accessibility to PET tracers. Regulatory bodies in the U.S., Europe, and Asia-Pacific have streamlined the approval process for investigational radiopharmaceuticals, accelerating clinical trials and commercial deployment. This growing ecosystem, supported by academic-industry collaboration, is propelling the global PET radiotracers market beyond conventional cancer diagnostics.

How Are Technological Advancements Influencing Radiotracer Development and Delivery?

PET radiotracer innovation is heavily reliant on advances in isotope production, radiochemistry automation, and tracer-specific targeting mechanisms. The miniaturization of cyclotrons and the deployment of generator-based isotope systems (e.g., 68Ge/68Ga generators) are facilitating onsite or near-site production of radiotracers, reducing the half-life-related limitations of traditional centralized supply chains. This has especially helped expand access in emerging markets and remote healthcare facilities.

Targeted radiotracers are now being designed with increased receptor specificity, allowing clinicians to differentiate between tumor subtypes and monitor treatment efficacy at the molecular level. For example, 18F-FES targets estrogen receptors in breast cancer, while PSMA-ligand-based tracers are reshaping prostate cancer diagnostics and theranostics. In neurology, 18F-florbetapir and 18F-flortaucipir are being used to image amyloid and tau pathology in Alzheimer's disease, supporting early-stage cognitive decline diagnostics.

Automation platforms for radiotracer synthesis, such as cassette-based synthesis modules and microfluidic chips, are reducing human error, enhancing purity, and accelerating production times. Radiopharmaceutical manufacturers are also working on cold kits and ready-to-use injectables to standardize procedures and reduce radiation exposure risks for medical staff. As radiotracers evolve to meet disease-specific diagnostic needs, technology is acting as the critical enabler of scalability, efficiency, and safety.

Which Clinical Applications and Geographic Regions Are Driving Market Expansion?

While oncology represents the core market for PET radiotracers, newer indications in neurology and cardiology are gaining traction. In Alzheimer's diagnostics, increased adoption of amyloid and tau PET imaging-supported by the approval of disease-modifying therapies-is creating new growth pathways. Similarly, cardiac PET imaging using perfusion tracers like 13N-ammonia and 82Rb is helping evaluate myocardial viability and ischemia in patients with complex coronary artery disease.

Geographically, North America remains the dominant market due to its strong radiopharmaceutical manufacturing base, high per capita healthcare spending, and the presence of advanced imaging centers. The U.S. FDA's support for radiotracer development under initiatives like the Drug Master File system and the Radioactive Drug Research Committee (RDRC) framework is expediting innovation. Europe is closely following, with Germany, the UK, and France leading the adoption curve due to well-established nuclear medicine departments and growing PET-MRI installations.

Asia-Pacific is emerging as the fastest-growing region, with countries like Japan, China, and South Korea investing in domestic isotope production and expanding their PET imaging infrastructure. India is witnessing increased public-private partnerships for PET tracer development, particularly in tertiary cancer centers. Latin America and parts of the Middle East are showing early signs of adoption, albeit limited by infrastructure gaps and high procurement costs.

What Is Driving Growth in the Global PET Radiotracers Market?

The growth in the global PET radiotracers market is driven by the rising incidence of cancer and neurodegenerative disorders, increasing adoption of hybrid imaging modalities, rapid expansion of nuclear medicine infrastructure, and continued innovation in disease-targeted tracer design. As precision diagnostics become central to modern healthcare, demand for radiotracers that provide early, accurate, and actionable insights is rising sharply.

Key growth drivers include government support for radiopharmaceutical R&D, streamlined regulatory frameworks, and advancements in radiochemistry automation. The clinical shift toward value-based care and personalized medicine is prompting hospitals to adopt molecular imaging tools that can reduce diagnostic ambiguity and improve therapeutic outcomes. Commercial players are responding with an expanding pipeline of radiotracers, robust supply networks, and companion diagnostics for targeted therapies.

Moreover, educational initiatives and nuclear medicine training programs are strengthening the global radiopharmacist talent pool, helping ensure safe and compliant tracer handling. As demand continues to diversify across clinical specialties and geographies, the PET radiotracers market is well-positioned to scale rapidly, anchoring its role as a cornerstone of next-generation medical imaging.

SCOPE OF STUDY:

The report analyzes the PET Radiotracers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Radiotracer (F-18 Radiotracer, Ga 68 Radiotracer, Other Radiotracer Types); Application (Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application, Other Applications); End-User (Hospitals End-User, Diagnostic Centers End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• ABX Advanced Biochemical Compounds GmbH
• Advanced Accelerator Applications
• AstraZeneca PLC
• Avid Radiopharmaceuticals
• Blue Earth Diagnostics
• Cardinal Health Inc.
• Eli Lilly and Company
• GE HealthCare
• IBA Radiopharma Solutions S.A.
• ImaginAb Inc.
• IXICO PLC
• Jubilant Pharma Limited
• Lantheus Holdings Inc.
• Neusoft Medical Systems Co. Ltd.
• Nordion Inc.
• Positron Corporation
• Radiomedix Inc.
• Siemens Healthineers AG
• SOFIE Biosciences Inc.
• Yantai Dongcheng Pharmaceutical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • PET Radiotracers - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Precision Oncology Throws the Spotlight on PET-Based Molecular Imaging Agents
  • Growth in Cancer Screening and Early Detection Programs Spurs Radiotracer Utilization
  • Expansion of Theranostics and Targeted Therapy Monitoring Drives Development of New PET Radiotracers
  • FDA Approvals of Novel PET Tracers for PSMA and Amyloid Imaging Accelerate Market Expansion
  • Increased Use of PET/CT and PET/MRI Hybrids Strengthens Business Case for Multi-Organ Tracers
  • Shift Toward Personalized Medicine Supports Companion Diagnostic Applications of Radiotracers
  • Technological Advancements in Cyclotron and Radiopharmacy Infrastructure Enhance Supply Efficiency
  • Emergence of AI in Image Interpretation Propels Integration with Biomarker-Specific Tracers
  • Surge in Neurology Imaging Drives Demand for PET Tracers in Alzheimer's and Parkinson's Diagnostics
  • Increased PET Application in Cardiovascular Imaging Expands Beyond Oncology Use Cases
  • R&D in Fluorine-18 and Gallium-68 Radiochemistry Fuels Development of Novel Agents
  • Strategic Collaborations Between Pharma and Imaging Providers Drive Companion Tracer Commercialization
  • Regulatory Streamlining of Investigational New Drug (IND) Applications Supports Faster Innovation Cycles
  • Limited Half-Life and Logistics of Short-Lived Isotopes Spur Investment in Decentralized Production
  • Growth in PET-Guided Biopsies and Therapeutic Planning Enhances Clinical Utility of Tracers
  • Clinical Trial Activity in Targeted Immunotherapies Spurs Use of Novel Radioligands
  • Rising Investments in Academic Radiochemistry Programs Expands Pipeline of First-in-Class Tracers
  • PET Radiotracer Market Expansion in Asia-Pacific Driven by Diagnostic Infrastructure Growth
  • Shift Toward Outpatient Imaging and Mobile PET Units Sustains Demand for On-Site Radiotracer Solutions
  • Increased Demand for Theranostic Pairings with Radiopharmaceutical Therapeutics Spurs Innovation
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World PET Radiotracers Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for PET Radiotracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for F-18 Radiotracer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for F-18 Radiotracer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for F-18 Radiotracer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Ga 68 Radiotracer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Ga 68 Radiotracer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Ga 68 Radiotracer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Radiotracer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Radiotracer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Other Radiotracer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Diagnostic Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Diagnostic Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Heart Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Gastrointestinal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Gastrointestinal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Gastrointestinal Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Endocrine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Endocrine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Endocrine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Neurological Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Neurological Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Neurological Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• JAPAN
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• CHINA
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• EUROPE
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for PET Radiotracers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• FRANCE
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• GERMANY
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for PET Radiotracers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• AUSTRALIA
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• INDIA
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for PET Radiotracers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for PET Radiotracers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• AFRICA
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION